Patterns of Treatment Adherence and Administration Preferences for People With Transthyretin Amyloid Cardiomyopathy: A Real-World Survey in Europe, the United States, and Japan

Onpattro (patisiran) - Alnylam, Sanofi

Vyndaqel (tafamidis meglumine) - Pfizer

Amvuttra (vutrisiran) - Alnylam

https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/paper/ispor-europe-2025/poster-session-4-2/patterns-of-treatment-adherence-and-administration-preferences-for-people-with-transthyretin-amyloid-cardiomyopathy-a-real-world-survey-in-europe-the-united-states-and-japan

Sanjana Chandrasekar, MPH 1; Jack Wright, MSc 2; Jade Garratt-Wheeldon, BSc 2; Janice Chung, MPH 1; Mónica Sofia Inês, MSc PhD 3; Christine L. Baker, MBA MPH JD 1; Ann Willet, MBA PhamrD 1; Pedro Ferreira Branquinho; Postgrad 3; Feng Dai, PhD 1; Alisha Braid, BSc 2; Brianne Kerr, BSc 2.

Nov 11, 2025